Personalized Cancer Medicine Market to Reach $507.23 Billion, Globally, by 2032 at 10.9% CAGR: Allied Market Research

Posted on by

The global personalized cancer medicine market is driven by factors such as a rise in prevalence of cancer, increase in demand for ideal therapeutics for treatment and rise in adoption of Artificial Intelligence (AI) based diagnosis. PORTLAND, Ore., July 12, 2023 /PRNewswire/ — Allied…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.